Poniard Pharmaceuticals Inc (PARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,000 | 3,850 | 5,630 | 1,440 | 11,170 |
| Marketable Securities | 0 | 0 | 0 | 3,040 | 12,320 |
| Other current assets | 250 | 340 | 470 | 730 | 860 |
| TOTAL | $2,250 | $4,190 | $6,100 | $5,210 | $24,350 |
| Non-Current Assets | |||||
| PPE Net | 710 | 800 | 800 | 790 | 1,220 |
| Other Non-Current Assets | 5,460 | 5,770 | 6,070 | 6,370 | 6,710 |
| TOTAL | $6,170 | $6,570 | $6,870 | $7,160 | $7,930 |
| Total Assets | $7,730 | $9,980 | $12,210 | $11,640 | $31,140 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,480 | 1,160 | 290 | 390 | 1,570 |
| Accrued Expenses | 1,490 | 920 | 990 | 1,220 | 2,960 |
| TOTAL | $2,970 | $2,080 | $1,280 | $1,610 | $12,420 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | 0 | 0 | 5,030 |
| TOTAL | $1,640 | $1,610 | $1,590 | $1,570 | $6,580 |
| Total Liabilities | $4,610 | $3,700 | $2,880 | $3,190 | $19,010 |
| Shareholders' Equity | |||||
| Common Shares | 1,190 | 1,190 | 1,180 | 970 | 960 |
| Retained earnings | -449,960 | -446,140 | -442,230 | -438,940 | -433,720 |
| Other shareholders' equity | 10 | 10 | -10 | 10 | 20 |
| TOTAL | $3,110 | $6,280 | $9,330 | $8,450 | $12,130 |
| Total Liabilities And Equity | $7,720 | $9,980 | $12,210 | $11,640 | $31,140 |